Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept

Rachel Choi; James Garritano; Mary Laird; Margaret Johnston; Elizabeth Tkachenko; William Damsky; Alicia J Little; Jennifer McNiff; Michael Girardi; Caroline A Nelson

doi:10.1016/j.jdcr.2022.09.009

Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept

JAAD Case Rep. 2022 Nov:29:139-141. doi: 10.1016/j.jdcr.2022.09.009. Epub 2022 Sep 20.

Authors

Affiliations

¹ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
² Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.

No abstract available

Keywords: COVID-19; SJS, Stevens Johnson syndrome; Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; cHIS, COVID-19-associated hyperinflammatory syndrome; etanercept; hyperinflammation; toxic epidermal necrolysis.

Publication types

Case Reports

Publication types

Grants and funding